Ondine Biomedical Inc (OBI) - Cash Flow Conversion Efficiency

Latest as of December 2025: -3.853x

Based on the latest financial reports, Ondine Biomedical Inc (OBI) has a cash flow conversion efficiency ratio of -3.853x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-13.44 Million ≈ $-1.64K USD) by net assets (GBX3.49 Million ≈ $424.53 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Ondine Biomedical Inc (OBI) total market value for the company's overall valuation and market capitalisation.

Ondine Biomedical Inc - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Ondine Biomedical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ondine Biomedical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ondine Biomedical Inc ranked by their cash flow conversion efficiency. See OBI operating cash to total liabilities to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Contagious Gaming Inc V:CNS	0.004x
Kodal Minerals PLC LSE:KOD	-0.035x
Tinybuild Inc LSE:TBLD	0.161x
OPTIMI HEALTH CORP. F:8BN	-0.094x
Onward Opportunities Ltd LSE:ONWD	-0.007x
CaNickel Mining Ltd V:CML	0.002x
Microlise Group PLC LSE:SAAS	0.055x
Sunindo Adipersada Tbk Pt JK:TOYS	-0.001x

Annual Cash Flow Conversion Efficiency for Ondine Biomedical Inc (2001–2025)

The table below shows the annual cash flow conversion efficiency of Ondine Biomedical Inc from 2001 to 2025. View Ondine Biomedical Inc (OBI) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX3.49 Million ≈ $424.53	GBX-23.90 Million ≈ $-2.91K	-6.851x	-204.17%
2024-12-31	GBX6.88 Million ≈ $836.73	GBX-15.49 Million ≈ $-1.88K	-2.252x	+65.60%
2023-12-31	GBX2.08 Million ≈ $253.68	GBX-13.65 Million ≈ $-1.66K	-6.548x	-366.49%
2022-12-31	GBX11.64 Million ≈ $1.42K	GBX-16.34 Million ≈ $-1.99K	-1.404x	-231.98%
2021-12-31	GBX29.66 Million ≈ $3.61K	GBX-12.54 Million ≈ $-1.53K	-0.423x	-325.93%
2020-12-31	GBX-33.83 Million ≈ $-4.12K	GBX-6.33 Million ≈ $-770.30	0.187x	-35.38%
2019-12-31	GBX-26.07 Million ≈ $-3.17K	GBX-7.55 Million ≈ $-918.74	0.290x	-48.60%
2018-12-31	GBX-17.90 Million ≈ $-2.18K	GBX-10.08 Million ≈ $-1.23K	0.563x	-29.97%
2017-12-31	GBX-6.55 Million ≈ $-796.70	GBX-5.27 Million ≈ $-640.96	0.805x	+108.26%
2010-12-31	GBX279.19K ≈ $33.97	GBX-2.72 Million ≈ $-330.96	-9.743x	-262.05%
2009-12-31	GBX1.28 Million ≈ $155.48	GBX-3.44 Million ≈ $-418.39	-2.691x	+59.70%
2008-12-31	GBX1.34 Million ≈ $162.71	GBX-8.93 Million ≈ $-1.09K	-6.677x	-508.20%
2007-12-31	GBX10.84 Million ≈ $1.32K	GBX-11.90 Million ≈ $-1.45K	-1.098x	-67.96%
2006-12-31	GBX16.59 Million ≈ $2.02K	GBX-10.84 Million ≈ $-1.32K	-0.654x	-28.61%
2005-12-31	GBX16.50 Million ≈ $2.01K	GBX-8.39 Million ≈ $-1.02K	-0.508x	-274.72%
2003-08-31	GBX-227.62K ≈ $-27.70	GBX-66.20K ≈ $-8.06	0.291x	+264.97%
2002-08-31	GBX-143.28K ≈ $-17.43	GBX25.26K ≈ $3.07	-0.176x	-396.57%
2001-08-31	GBX1.39 Million ≈ $169.63	GBX-49.50K ≈ $-6.02	-0.036x	--

About Ondine Biomedical Inc

LSE:OBI UK Biotechnology

Market Cap

$679.55K

GBX5.59 Billion GBX

Market Cap Rank

#30907 Global

#873 in UK

Share Price

GBX10.75

Change (1 day)

+0.00%

52-Week Range

GBX8.00 - GBX15.40

All Time High

GBX58.50